|
 |
|
|
90-minute Webcast on CD Your Best Opportunities for Generic Drug Savings:
Drugs with U.S. sales of $25 billion to $30 billion could lose patent protection over the next three years. The majority are treatments for health conditions prevalent in many employer and union groups. With the introduction of generic equivalents costing 30% to 80% less, payers can realize hefty savings. When using low-cost generics, beneficiaries are more likely to continue taking critical maintenance medications, helping to avert serious and costly medical utilization. In this Webcast, you’ll learn how to get maximum value from generics by strategizing around health conditions in your population. Learning Objectives This Webcast is designed to help human resource professionals, managed care pharmacy professionals, PBMs and consultants to: • Identify diseases and conditions prevalent in the ambulatory population impacted by drugs coming off patent. • Prioritize disease states and conditions for optimizing generic dispensing. • Understand how this approach to increasing generic dispensing parallels wellness and disease managements • Examine plan design approaches for creating incentives for generic drugs where medically appropriate • Articulate the importance of clinical management strategies by disease state or condition that will affect drug • Identify current and future saving potential from generic drugs. • Review pending legislation to get generics and generic biologicals to market faster. Speakers Bridget Eber, PharmD is the National Pharmacy Practice leader for Towers Perrin, a global human resource consulting firm. She has a diverse background in the pharmacy practice with experience that spans 30 years. Bridget concentrated on the clinical practice in teaching hospitals during the first fifteen years of her career. She spent the next three years focused on managed care administration for a large national health plan provider. She has consulted in employee health care benefits since 1997. Prior to joining Towers Perrin, she founded and then led the National Pharmacy Practice at a global outsourcing and consulting firm. Bridget pioneered a number of pharmacy management strategies, including implementing “closed” formularies, step therapy programs, price transparency and aligning cost with quality management incentives. She views pharmacy management as an integral component of condition management, consumerism and retiree health care benefits. Bridget frequently speaks at seminars and conferences in the U.S. and abroad, and writes on pharmacy benefits. She holds BS and PharmD degrees from the University of Illinois. Jake Nichols, PharmD, MBA, is the Director of Clinical Affairs for Clinical Pharmacy Services at Commonwealth Medicine in Worcester, Massachusetts. The organization provides clinical services, including new drug reviews, therapeutic class reviews, and retrospective drug utilization review for many managed care and Medicaid organizations. Jake currently provides global supervision over all clinical programs and clinical pharmacist staff. He is also director of the managed care residency program. He is actively involved in teaching and currently maintains academic appointments at Northeastern University and the Massachusetts College of Pharmacy and Health Sciences.
|
|
Copyright 2007 Pharmacy Benefit Management Institute, LP
